Literature DB >> 21601105

Lentiviral vectors to study stochastic noise in gene expression.

Kate Franz1, Abhyudai Singh, Leor S Weinberger.   

Abstract

Lentiviral vectors are vehicles for gene delivery that were originally derived from the human immunodeficiency virus type-1 (HIV-1) lentivirus. These vectors are defective for replication, and thus considered relatively safe, but are capable of stably integrating into the genomic DNA of a broad range of dividing and nondividing mammalian cell types. The ability to stably integrate at semi-random genomic positions make lentiviral vectors a unique and ideal tool for studying stochastic variation in gene expression. Here, we describe the experimental and mathematical methods for using lentiviral vectors to study stochastic noise in gene expression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601105     DOI: 10.1016/B978-0-12-385075-1.00026-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  4 in total

1.  Microwell devices with finger-like channels for long-term imaging of HIV-1 expression kinetics in primary human lymphocytes.

Authors:  Brandon S Razooky; Edgar Gutierrez; Valeri H Terry; Celsa A Spina; Alex Groisman; Leor S Weinberger
Journal:  Lab Chip       Date:  2012-11-07       Impact factor: 6.799

Review 2.  Mucopolysaccharidoses type I gene therapy.

Authors:  Sarah C Hurt; Patricia I Dickson; David T Curiel
Journal:  J Inherit Metab Dis       Date:  2021-07-09       Impact factor: 4.750

3.  Transcriptional Bursting Explains the Noise-Versus-Mean Relationship in mRNA and Protein Levels.

Authors:  Roy D Dar; Sydney M Shaffer; Abhyudai Singh; Brandon S Razooky; Michael L Simpson; Arjun Raj; Leor S Weinberger
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

4.  Control of Hox transcription factor concentration and cell-to-cell variability by an auto-regulatory switch.

Authors:  Dimitrios K Papadopoulos; Kassiani Skouloudaki; Ylva Engström; Lars Terenius; Rudolf Rigler; Christoph Zechner; Vladana Vukojević; Pavel Tomancak
Journal:  Development       Date:  2019-01-25       Impact factor: 6.868

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.